The July 2011 issue of Nature Reviews Rheumatology features four Reviews from key researchers who gave talks at the inaugural Excellence in Rheumatology Annual Conference held in Istanbul in February 2011. The topics covered were independently selected from the conference program by the Nature Reviews Rheumatology editorial team. These Reviews—and the selected articles from across the Nature Publishing Group that appear here as part of this Nature Clinical Collection—discuss developments in two fast-moving fields of rheumatology, those of inflammatory arthritis and comorbidities. Topics covered include the epidemiology, diagnosis, outcome and management of early inflammatory arthritis, and the epidemiology and impact of cardiovascular disease as well as other comorbidities, such as stress, malignancies and infections, on the lives of patients living with rheumatic disease. The Reviews in this Nature Clinical Collection have been made freely available for 3 months thanks to support from the Excellence in Rheumatology Conference.



REVIEWS

The epidemiology of early inflammatory arthritis

Johanna M. W. Hazes & Jolanda J. Luime

doi:10.1038/nrrheum.2011.78

Nature Reviews Rheumatology 7, 381-390 (2011)

Emerging data from cohorts of patients with recent-onset arthritis provide valuable information about the incidence and outcomes of early inflammatory disease, and about the risk factors for transition to full-blown rheumatoid arthritis, which could help improve the diagnosis and therapy of such conditions.

Anti-CCP antibodies: the past, the present and the future

Walther J. van Venrooij, Joyce J. B. C. van Beers & Ger J. M. Pruijn

doi:10.1038/nrrheum.2011.76

Nature Reviews Rheumatology 7, 391-398 (2011)

Anti-citrullinated peptide antibodies (ACPA) are an important feature of rheumatoid arthritis (RA), and the presence of these autoantibodies is associated with a more-erosive disease course. In this Review, the authors provide an overview of the discovery and development of ACPA as a biomarker in RA, and discuss the future research directions that might further enhance its clinical utility.

Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE

Deborah P. M. Symmons & Sherine E. Gabriel

doi:10.1038/nrrheum.2011.75

Nature Reviews Rheumatology 7, 399-408 (2011)

Traditional cardiovascular risk factors combine, in the context of inflammatory rheumatic diseases, with disease-related and treatment-related risk factors, to determine a patient's overall risk of cardiovascular disease (CVD). These competing risks are explored in this Review, which summarizes why CVD risk is increased in these patients, and what remains to understand before patients can be offered the best advice about CVD risk management.

Stress and resilience in rheumatic diseases: a review and glimpse into the future

Andrea W. M. Evers, Alex Zautra & Kati Thieme

doi:10.1038/nrrheum.2011.80

Nature Reviews Rheumatology 7, 409-415 (2011)

Adapting to life with a chronic illness is difficult—rheumatic diseases can have profound effects on long-term quality of life. A patient's resilience to the challenges of chronic illness is determined by a number of factors that are increasingly understood, and which are outlined in this Review. The authors summarize developments in the psychological care of patients in clinical rheumatology practice, and describe novel approaches to optimizing this care.

Top

Extra navigation

Sponsored by

natureevents

Advertisement